<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T01:37:39Z</responseDate>
  <request identifier="oai:figshare.com:article/34018695" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34018695</identifier>
        <datestamp>2026-09-29T00:04:27Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_69</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>De Novo Discovery of
Cysteine-Targeted Reversible
Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display</dc:title>
          <dc:creator>Yuqian Zhang (615460)</dc:creator>
          <dc:creator>Mengzhu Qi (17756760)</dc:creator>
          <dc:creator>Xiankai Liu (188445)</dc:creator>
          <dc:creator>Yukun Zhou (8257716)</dc:creator>
          <dc:creator>Yanmei Wang (392327)</dc:creator>
          <dc:creator>Xing Xiao (134047)</dc:creator>
          <dc:creator>Yapei Wu (4168285)</dc:creator>
          <dc:creator>Wei Gao (2085)</dc:creator>
          <dc:creator>Yang Liu (4829)</dc:creator>
          <dc:creator>Yiwu Zheng (1466191)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Inorganic Chemistry</dc:subject>
          <dc:subject>prolonged residence time</dc:subject>
          <dc:subject>mechanistic analysis reveals</dc:subject>
          <dc:subject>maintaining prolonged residence</dc:subject>
          <dc:subject>de novo identification</dc:subject>
          <dc:subject>de novo discovery</dc:subject>
          <dc:subject>complex cellular environment</dc:subject>
          <dc:subject>5 – 100</dc:subject>
          <dc:subject>transient binding dynamics</dc:subject>
          <dc:subject>binding potency relative</dc:subject>
          <dc:subject>unsaturated nitrile electrophiles</dc:subject>
          <dc:subject>reversible covalent warhead</dc:subject>
          <dc:subject>cysteine residues offers</dc:subject>
          <dc:subject>32 &lt;/ b</dc:subject>
          <dc:subject>retains binding</dc:subject>
          <dc:subject>selected warhead</dc:subject>
          <dc:subject>designing electrophiles</dc:subject>
          <dc:subject>k &lt;/</dc:subject>
          <dc:subject>&lt;/ sub</dc:subject>
          <dc:subject>work establishes</dc:subject>
          <dc:subject>rich conditions</dc:subject>
          <dc:subject>react rapidly</dc:subject>
          <dc:subject>powerful strategy</dc:subject>
          <dc:subject>potent ligand</dc:subject>
          <dc:subject>nanomolar affinities</dc:subject>
          <dc:subject>mediated targeting</dc:subject>
          <dc:subject>keep pace</dc:subject>
          <dc:subject>keap1 enabled</dc:subject>
          <dc:subject>keap1 cys434</dc:subject>
          <dc:subject>generating potent</dc:subject>
          <dc:subject>general strategy</dc:subject>
          <dc:subject>fold improvement</dc:subject>
          <dc:subject>displayed peptides</dc:subject>
          <dc:subject>capture keap1</dc:subject>
          <dc:subject>balanced reactivity</dc:subject>
          <dc:subject>&gt;&lt; sub</dc:subject>
          <dc:subject>7 nm</dc:subject>
          <dc:description>Reversible covalent targeting of cysteine residues offers
a powerful
strategy for generating potent and tunable ligands, but designing
electrophiles with balanced reactivity, stability, and reversible
binding remains challenging. Here, we systematically optimized reversible
α,β-unsaturated nitrile electrophiles and incorporated
the selected warhead with prolonged residence time into phage-displayed
peptides to construct a library of reversible covalent cyclic peptides.
Screening this library against Keap1 enabled the de novo identification
of ligands with nanomolar affinities, demonstrating a 5–100-fold
improvement in binding potency relative to the corresponding noncovalent
cyclic peptides. The most potent ligand, cyclic peptide &lt;b&gt;32&lt;/b&gt;, exhibits a &lt;i&gt;K&lt;/i&gt;&lt;sub&gt;i&lt;/sub&gt; of 3.7 nM, retains binding
under thiol-rich conditions, and can capture Keap1 from a complex
cellular environment. Mechanistic analysis reveals that peptide-mediated
targeting in cyclic peptide &lt;b&gt;32&lt;/b&gt; positions the reversible
covalent warhead to react rapidly with Keap1 Cys434 while maintaining
prolonged residence, allowing covalent bond formation to keep pace
with the transient binding dynamics of the peptide–protein
interaction. Overall, this work establishes a general strategy for
integrating tunable reversible covalent chemistry into genetically
encoded peptide libraries, enabling de novo discovery of high-affinity
ligands.</dc:description>
          <dc:date>2026-09-28T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/jacs.6c17599.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/De_Novo_Discovery_of_Cysteine-Targeted_Reversible_Covalent_Cyclic_Peptides_with_Prolonged_Residence_Time_via_Phage_Display/34018695</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
